AngioDynamics Reports Fiscal 2019 Third Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
AngioDynamics (ANGO) Misses Q3 EPS by 3c, Revenues Miss; Reiterates FY19 EPS/Revenue Mid-Point Guidance Below Consensus
April 2, 2019 7:04 AM EDTAngioDynamics (NASDAQ: ANGO) reported Q3 EPS of $0.19, $0.03 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $86.3 million versus the consensus estimate of $88.3 million.
Net sales of $86.3 million, an increase of 3.0% year over yearGross margin declined 10 basis points year over year to 54.1%GAAP EPS of $0.02 per share;... More